BL
Last reporting period 30 Jun, 2024
Updated 19 Sep, 2024
Last price
—
Market cap $B
1.094
Exchange
XNAS - Nasdaq
0.32 B
Last period Equity ,USD
594%
Equity has increased in 5 years
What is Equity ?
Equity is the amount of money that the company would receive if all its assets were sold and all debt obligations were paid off.
See also BioLife
Company Analysis
BLFS valuation, rating, competitors, insights and company profile
Eyestock Rating
BLFS financial analysis by Eyestock methodology
Valuation
BLFS valuation using historical relative method
Statements
BLFS Income Statements, Balance Sheet and Cash Flow Statements
Dividends
BLFS dividend yield and annual dividend
Equity is the amount of money that the company would receive if all its assets were sold and all debt obligations were paid off.
BioLife`s Equity for the period ended 2024-06-30 is 0.32 B USD
